Atlas Trials

Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.

Clinical trial NCT01227811 · UNKNOWN

Trial details

NCT number
NCT01227811
Sponsor
Center for Clinical Pharmacology Research Bdbeq S.A.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalency
Start date
2010-11-01
Primary completion
2010-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.